Verrica Pharmaceuticals (VRCA) Return on Assets (2018 - 2026)
Verrica Pharmaceuticals (VRCA) posted quarterly Return on Assets of 0.01% for Q1 2026, up 1.0% year-over-year from 0.01% in Q1 2025, and down 4.65% quarter-over-quarter from 0.01% in Q4 2025.
Verrica Pharmaceuticals (VRCA) Return on Assets (2018 - 2026) Analysis & Trends
Verrica Pharmaceuticals' Return on Assets history runs 9 years deep, the most recent figure standing at 0.01% for Q1 2026.
- In Q1 2026, Return on Assets rose 1.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.01% (up 1.0% YoY), while the FY2025 annual figure was 0.02%, changed 0.0% from the prior year.
- Return on Assets for Q1 2026 stood at 0.01%, down from 0.01% in the prior quarter.
- The five-year high for Return on Assets was 0.0% in Q2 2023, with the low at 0.65% in Q3 2024.
- The 5-year median for Return on Assets is 0.01% (2023), against an average of 0.13%.
- The sharpest annual moves came in 2024 and 2025: Return on Assets sank 65 bps in 2024, then surged 65 bps in 2025.
- Verrica Pharmaceuticals' Return on Assets stood at 0.01% in 2022, then plunged by 57 bps to 0.01% in 2023, then tumbled by 7926 bps to 0.64% in 2024, then surged by 99 bps to 0.01% in 2025, then retreated by 5 bps to 0.01% in 2026.
- Business Quant data shows VRCA's Return on Assets at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - | 0.00% |
| 10 | Verrica Pharmaceuticals | 99.71 Mn | 88.51 Mn | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01% |
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | -0.64% |
| Sep 30, 2024 | -0.65% |
| Jun 30, 2024 | -0.47% |
| Mar 31, 2024 | -0.37% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | 0.00% |